Meet our founders
Founded at Yale University, forEVA brings together expertise in biomedical engineering, healthcare, and law to rethink how women understand their bodies. We believe meaningful health insights shouldn't depend on invasive testing or occasional snapshots, but should be accessible through technology that fits seamlessly into everyday life.
Jaya Dadwal, MPH
Co-Founder & Chief Executive Officer
Jaya is an Australian-qualified lawyer with a background in health policy, reproductive health advocacy, and healthcare management. She holds a Bachelor of Politics, Philosophy and Economics from the Australian National University, a Bachelor of Laws with First Class Honours from the University of Technology Sydney, and a Master of Public Health in Health Care Management from Yale University.
Her work spans medical negligence litigation, reproductive health research, and public policy advocacy. A former Research Fellow at Yale Law School's Solomon Center for Health Law and Policy, she has published research on gendered harms in healthcare and advocated for women's health legislation. As Co-Founder and CEO, Jaya leads forEVA's commercial and strategic development, advancing her commitment to better sex-specific research, informed patient decision-making, and greater access to meaningful health information.
Emily is a biomedical and chemical engineer with a Ph.D. in Biomedical Engineering from Yale University, as well as a Bachelor's degree in Chemical Engineering and a Master's degree in Pharmaceutical Engineering from the University of Michigan. Her research spans biomaterials, drug delivery, and computational modeling, including the development of nanoparticle-based therapies for pregnancy complications. She also brings industry experience from Biogen in gene therapy development, spanning formulation, manufacturing, and clinical translation.
As Co-Founder and Chief Scientific Officer, Emily leads forEVA's scientific and technical development, overseeing molecular biosensing, microfluidics, device integration, and computational approaches to interpreting longitudinal hormone data. Her multidisciplinary background in engineering, quantitative modeling, and women's health is central to developing accessible, non-invasive hormone monitoring technologies.Co-Founder & Chief Scientific Officer
Emily Deschenes, PhD
Guided by expertise across science, medicine, and engineering: meet our advisors
Alla Vash-Margita, MD
Medical Advisor
Dr Vash-Margita is an Associate Professor of Obstetrics, Gynecology and Reproductive Sciences and Director of Pediatric and Adolescent Gynecology at Yale School of Medicine. With clinical expertise in menstrual and hormonal disorders, including polyendocrine metabolic ovarian syndrome (PMOS) and endometriosis, she advises forEVA on the clinical applications of longitudinal hormone monitoring and addressing gaps in women's reproductive healthcare.
Aaron Lazorwitz, MD, PhD
Clinical Advisor
Dr Lazorwitz is an Associate Professor of Obstetrics, Gynecology and Reproductive Sciences and Associate Program Director of the Complex Family Planning Fellowship at Yale School of Medicine. With expertise in reproductive endocrinology, hormonal contraception, and personalized reproductive healthcare, his research examines how individual biological differences influence reproductive health and responses to hormonal interventions. He advises forEVA on the clinical interpretation and applications of longitudinal hormone monitoring, supporting the development of more personalized approaches to women's healthcare.
Harvey Kliman, MD, PhD
Research Advisor
Dr Kliman is a Research Scientist in Obstetrics, Gynecology and Reproductive Sciences and Director of the Reproductive and Placental Research Unit at Yale School of Medicine. With expertise in reproductive pathology, endometrial biology, and pregnancy complications, he pioneered the Endometrial Function Test, translating molecular research into clinical diagnostics. He advises forEVA on reproductive biology, biomarker interpretation, and the translation of longitudinal hormone data into clinically meaningful insights.
Jeffrey McCutcheon, PhD
Technical Advisor
Dr McCutcheon is the Centennial Professor of Engineering and General Electric Professor of Advanced Manufacturing at the University of Connecticut, where he also directs the Connecticut Center for Applied Separations Technology. An internationally recognized expert in membrane science, his research focuses on advanced membrane materials, separation technologies, and novel manufacturing techniques. He advises forEVA on membrane design, material selection, and integration of membrane technologies into its saliva-based biosensing platform.
Sihong Wang, PhD
Technical Advisor
Dr Wang is an Associate Professor of Molecular Engineering at the University of Chicago's Pritzker School of Molecular Engineering. An internationally recognized researcher in bioelectronics and advanced biosensing technologies, his work focuses on developing novel electronic materials and devices for reliable, long-term physiological monitoring. He advises forEVA on electrochemical biosensing, sensor performance, and the integration of molecular sensing technologies into its saliva-based hormone monitoring platform.
